By using product development teams with experience gained from industries beyond the IVD world, IVD companies can draw on trends from seemingly unrelated fields to deliver breakthrough ideas that enable them to leap ahead of their competitors and redefine markets.

by: Jari Palander

A review of current issues encountered when sourcing blood-based clinical patient samples and the future outlook for IVD manufacturers.

by: Simon Packer, Keli Stockbridge, and Philip Jewess

Hematology instrumentation developers must be equipped to meet technology challenges coupled with IVD manufacturers’ demands for speed-to-market and cost efficiency.

by: Henri Champseix and Eric Jolain

Diagnostic developers are invited to submit concept sheets to the CDRC to request evaluation of a technology at clinical study sites in TB-endemic countries.

by: Jerrold Ellner, MD

Despite advances in point of care, mid- to large-volume IVD instruments remain cost-effective and highly reliable choices for labs. Although they are complex and expensive to develop, these instruments answer a global need and retain several advantages over their smaller, more-portable counterparts.

by: Interview by Richard Park

The editors of IVD Technology asked industry analysts to share their thoughts and opinions on next year’s elections, the IVD-related issues that could be raised during the election year, and their potential impact on the IVD industry and IVD manufacturers.

Sony bought Micronics to boost its own R&D in the area of point-of-care diagnostic equipment and to accelerate commercialization of these products.

by: Maureen Kingsley

by: Richard Park

by: Maureen Kingsley

Understanding European requirements for performance-evaluation studies is crucial for marketing devices in European nations.

by: Maria E. Donawa